Literature DB >> 3958114

Rates of senile dementia, Alzheimer's type, in the Baltimore Longitudinal Study.

R B Sayetta.   

Abstract

Research participants (519) in the ongoing Baltimore Longitudinal Study, Gerontology Research Center, National Institute on Aging, from 1958-1978 were screened for new onset of Senile Dementia-Alzheimer's Type (SDAT), a global and progressive cognitive disorder. Their medical record abstracts were reviewed by two psychiatrists, who applied algorithmic criteria to identify 27 incident cases and date onsets. Intrarater bias, interrater reliability, and concurrent validity of the case ascertainment methods were assessed. A radix was created to estimate age-specific incidence rates, prevalence rates, remaining lifetime morbid risk for the disease-free and expected years of impairment with disease. Incidence was modeled as an exponential function of chronological age beyond 60. Survival analysis failed to detect premature death among SDAT cases; death rates depended only on chronological age--not on disease acquisition, duration, or age at onset. Prevalence at every age depended on incidence, exceeding 50% among those 95 and over.

Entities:  

Mesh:

Year:  1986        PMID: 3958114     DOI: 10.1016/0021-9681(86)90049-4

Source DB:  PubMed          Journal:  J Chronic Dis        ISSN: 0021-9681


  9 in total

1.  Metrifonate and dichlorvos: effects of a single oral administration on cholinesterase activity in rat brain and blood.

Authors:  V Hinz; S Grewig; B H Schmidt
Journal:  Neurochem Res       Date:  1996-03       Impact factor: 3.996

Review 2.  The epidemiology of dementia in North America.

Authors:  M R Eastwood; S L Rifat; D Roberts
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

3.  Can we afford not to evaluate services for elderly persons with dementia?

Authors:  G Worrall; L W Chambers
Journal:  Can Fam Physician       Date:  1989-03       Impact factor: 3.275

4.  [Not Available].

Authors:  G Worrall; L W Chambers
Journal:  Can Fam Physician       Date:  1990-10       Impact factor: 3.275

5.  The economic costs of Alzheimer's disease.

Authors:  J W Hay; R L Ernst
Journal:  Am J Public Health       Date:  1987-09       Impact factor: 9.308

6.  The US economic and social costs of Alzheimer's disease revisited.

Authors:  R L Ernst; J W Hay
Journal:  Am J Public Health       Date:  1994-08       Impact factor: 9.308

7.  Neuropathological changes in the cerebral cortex of 1258 cases from a geriatric hospital: retrospective clinicopathological evaluation of a 10-year autopsy population.

Authors:  P Giannakopoulos; P R Hof; S Mottier; J P Michel; C Bouras
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

8.  The Alzheimer's Disease Exposome.

Authors:  Caleb E Finch; Alexander M Kulminski
Journal:  Alzheimers Dement       Date:  2019-09-10       Impact factor: 21.566

Review 9.  Risk estimations, risk factors, and genetic variants associated with Alzheimer's disease in selected publications from the Framingham Heart Study.

Authors:  Galit Weinstein; Philip A Wolf; Alexa S Beiser; Rhoda Au; Sudha Seshadri
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.